Back to search

Article

Genetic Predictors of Response to Zolbetuximab in Gastric Adenocarcinoma

2026-01-01

Abstract excerpt

<h4>Background: </h4> /Objectives: The anti-CLDN18.2 antibody zolbetuximab has emerged as a novel therapeutic option for advanced gastric adenocarcinoma. However, robust predictive biomarkers for its efficacy remain an unmet need. <h4>Methods:</h4> Utilizing the Japanese Center for Cancer Genomics and Advanced Therapeutics database, we retrospectively analyzed the clinical and genomic profiles of 49 patients with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
aff9440b-0e2f-5caa-9b65-7c39aa1ebafc
DOI
10.20944/preprints202601.0008.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetic Predictors of Response to Zolbetuximab in Gastric AdenocarcinomaDOI 10.20944/preprints202601.0008.v1
Select a neighboring publication to make it the new centre.